Another study of advanced melanoma patients treated with combined CTLA-4 and PD-1 blockade (n = 40) found that responders had enriched levels of Bacteroides stercoris, Parabacteroides distasonis, and Fournierella massiliensis (36). The gene discussed is CTLA4; the disease is melanoma.